Drug recall · February 8, 2017
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) recall
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13) Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat, India.
- Lots / codes
a) JKP5530A Exp. 12/17, JKP3991A Exp. 11/17, JKR6535A Exp. 07/18 b) JKP5529A Exp. 11/17
- Quantity
- 8,537 bottles
- Company
- Sun Pharmaceutical Industries, Inc., Cranbury, NJ
- Distribution
- Nationwide
- Initiated
- January 12, 2017 · Voluntary: Firm initiated
- Classified
- February 2, 2017
- Reported
- February 8, 2017
- Ended
- June 29, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carbidopa / levodopa
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.